Country Profile

Norway

Norway is an emerging destination for Indian pharmaceutical exports — $9.74M in FY 2025–26, with 1.6× growth over the past decade. Medicine Ingredients accounts for 82% of shipments. The compound annual growth rate since FY2015 stands at 4.6%.

🇳🇴 $9.74M · 1.6× growth since FY2015 · 4.6% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$9.74M
Exports FY2025–26 DGCIS
1.6×
Growth FY2015→2026
4.6%
CAGR FY2015→2026
82%
Medicine Ingredients Share
4
Product Categories Supplied
Norway is an emerging destination for Indian pharmaceutical exports — $9.74M in FY 2025–26, with 1.6× growth over the past decade. Medicine Ingredients accounts for 82% of shipments. The compound annual growth rate since FY2015 stands at 4.6%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $8.03M (82.4%) Surgical & Hospital Supplies $1.53M (15.7%) Traditional & Herbal $123K (1.3%) Medicines $57K (0.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Norway in the RBI overseas direct investment dataset (2011–2026).